Works about PSORIATIC arthritis
Results: 5000
Persistence After Switching From Adalimumab Biosimilar MSB11022 to Adalimumab Biosimilar GP2017 in Patients With Chronic Inflammatory Rheumatic Diseases.
- Published in:
- Journal of Pharmacy Technology, 2025, v. 41, n. 2, p. 90, doi. 10.1177/87551225241306675
- By:
- Publication type:
- Article
Role of Serum and Urinary Orsomucoid Protein A in Psoriatic Arthritis Patients and Their Relation to Disease Activity.
- Published in:
- Zagazig University Medical Journal, 2025, v. 31, p. 185, doi. 10.21608/ZUMJ.2024.329250.3649
- By:
- Publication type:
- Article
Therapeutic Advancements in Psoriasis and Psoriatic Arthritis.
- Published in:
- Journal of Clinical Medicine, 2025, v. 14, n. 4, p. 1312, doi. 10.3390/jcm14041312
- By:
- Publication type:
- Article
Pediatric Society of the African League Against Rheumatism juvenile idiopathic arthritis recommendations for enthesitis-related arthritis and juvenile psoriatic arthritis.
- Published in:
- Clinical Rheumatology, 2025, v. 44, n. 3, p. 901, doi. 10.1007/s10067-025-07334-x
- By:
- Publication type:
- Article
External validation of the accuracy of cardiovascular risk prediction tools in psoriatic disease: a UK Biobank study.
- Published in:
- Clinical Rheumatology, 2025, v. 44, n. 3, p. 1151, doi. 10.1007/s10067-025-07325-y
- By:
- Publication type:
- Article
Transition-related outcomes among a cohort of patients with juvenile idiopathic arthritis.
- Published in:
- Clinical Rheumatology, 2025, v. 44, n. 3, p. 1377, doi. 10.1007/s10067-025-07317-y
- By:
- Publication type:
- Article
Type D personality and social inhibition: drivers of cardiovascular risk and reduced physical activity in psoriatic arthritis.
- Published in:
- Clinical Rheumatology, 2025, v. 44, n. 3, p. 1163, doi. 10.1007/s10067-025-07312-3
- By:
- Publication type:
- Article
Clinical features of inflammatory arthritis in daily practice—China's perspective.
- Published in:
- Clinical Rheumatology, 2025, v. 44, n. 3, p. 969, doi. 10.1007/s10067-024-07262-2
- By:
- Publication type:
- Article
Management of rheumatoid arthritis in primary care.
- Published in:
- Practice Nursing, 2017, v. 28, n. 5, p. 208, doi. 10.12968/pnur.2017.28.5.208
- By:
- Publication type:
- Article
Osteoporosis in psoriatic arthritis: Is there any?
- Published in:
- Wiener Klinische Wochenschrift, 2011, v. 123, n. 23/24, p. 743, doi. 10.1007/s00508-011-0095-8
- By:
- Publication type:
- Article
Increased Prevalence of Metabolic Syndrome in Patients with Psoriatic Arthritis.
- Published in:
- Metabolic Syndrome & Related Disorders, 2014, v. 12, n. 1, p. 43, doi. 10.1089/met.2013.0039
- By:
- Publication type:
- Article
Increased Prevalence of the Metabolic Syndrome in Patients with Psoriatic Arthritis.
- Published in:
- Metabolic Syndrome & Related Disorders, 2010, v. 8, n. 4, p. 331, doi. 10.1089/met.2009.0124
- By:
- Publication type:
- Article
Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a Phase 3 double-blind randomised placebo-controlled study (RAPID-PsA).
- Published in:
- Current Medical Literature: Rheumatology, 2014, v. 33, n. 1, p. 14
- By:
- Publication type:
- Article
The Framingham Risk score underestimates the extent of subclinical atherosclerosis in patients with psoriatic disease.
- Published in:
- Current Medical Literature: Rheumatology, 2013, v. 32, n. 4, p. 133
- By:
- Publication type:
- Article
Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a Phase 3 double-blind randomised placebo-controlled study (RAPID-PsA).
- Published in:
- Current Medical Literature: Rheumatology, 2013, v. 32, n. 4, p. 131
- By:
- Publication type:
- Article
Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the Phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial.
- Published in:
- Current Medical Literature: Rheumatology, 2013, v. 32, n. 4, p. 129
- By:
- Publication type:
- Article
Efficacy and safety of open-label etanercept on extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis and psoriatic arthritis: part 1 (week 12) of the CLIPPER study.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
Switching between TNF inhibitors in psoriatic arthritis: data from the NOR-DMARD study.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
Leflunomide in psoriatic arthritis: results from a large European prospective observational study.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
Disease-Modifying Antirheumatic Drugs or Biological Blockers in Psoriatic Arthritis?
- Published in:
- Current Medical Literature: Rheumatology, 2013, v. 32, n. 3, p. 77
- By:
- Publication type:
- Article
Serum adipokines in patients with psoriatic arthritis and psoriasis alone and their correlation with disease activity.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
Efficacy and safety of adalimumab for the treatment of peripheral arthritis in spondyloarthritis patients without ankylosing spondylitis or psoriatic arthritis.
- Published in:
- Current Medical Literature: Rheumatology, 2013, v. 32, n. 1, p. 30
- By:
- Publication type:
- Article
Spondyloarthritis.
- Published in:
- Current Medical Literature: Rheumatology, 2011, v. 30, n. 3, p. 83
- Publication type:
- Article
Association study of the HLA class I system with psoriatic arthritis in Southern Tunisia: a case–control study.
- Published in:
- Clinical Rheumatology, 2025, v. 44, n. 2, p. 707, doi. 10.1007/s10067-024-07290-y
- By:
- Publication type:
- Article
Refractory psoriatic arthritis: emerging concepts in whole process management.
- Published in:
- Clinical Rheumatology, 2025, v. 44, n. 2, p. 583, doi. 10.1007/s10067-024-07267-x
- By:
- Publication type:
- Article
Risk prediction model for psoriatic arthritis: NHANES data and multi-algorithm approach.
- Published in:
- Clinical Rheumatology, 2025, v. 44, n. 1, p. 277, doi. 10.1007/s10067-024-07244-4
- By:
- Publication type:
- Article
Association between patient's psychological health and discordance in patient-physician assessment of psoriatic arthritis.
- Published in:
- Clinical Rheumatology, 2025, v. 44, n. 1, p. 291, doi. 10.1007/s10067-024-07202-0
- By:
- Publication type:
- Article
Structured and prompt treatment of early arthritis in clinical practice leverages window of opportunity and leads to excellent clinical outcomes: an innovative retrospective cohort study.
- Published in:
- Clinical Rheumatology, 2024, v. 43, n. 12, p. 3941, doi. 10.1007/s10067-024-07192-z
- By:
- Publication type:
- Article
An atypical nail lesion in a patient with psoriatic disease.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Durable control of psoriatic arthritis with guselkumab across domains and patient characteristics: post hoc analysis of a phase 3 study.
- Published in:
- Clinical Rheumatology, 2024, v. 43, n. 8, p. 2551, doi. 10.1007/s10067-024-06991-8
- By:
- Publication type:
- Article
Mean platelet volume may not be associated with disease activity in patients with psoriatic arthritis.
- Published in:
- 2024
- By:
- Publication type:
- Letter to the Editor
Hematological indices in psoriatic enthesopathy: relation to clinical and ultrasound evaluation.
- Published in:
- Clinical Rheumatology, 2024, v. 43, n. 6, p. 1909, doi. 10.1007/s10067-024-06951-2
- By:
- Publication type:
- Article
Opioid use surrounding diagnosis and follow-up in patients with ankylosing spondylitis, psoriatic arthritis, and rheumatoid arthritis: Results from US claims databases.
- Published in:
- Clinical Rheumatology, 2024, v. 43, n. 6, p. 1897, doi. 10.1007/s10067-024-06945-0
- By:
- Publication type:
- Article
Meaningful patient engagement in inflammatory arthritis: development of the Patient Motivation Questionnaire.
- Published in:
- Clinical Rheumatology, 2024, v. 43, n. 6, p. 1793, doi. 10.1007/s10067-017-3605-x
- By:
- Publication type:
- Article
Correction to: What is the association of depression with clinical response to therapy in patients with psoriatic arthritis treated with biologic disease-modifying antirheumatic drugs?
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Sex-specific differences in patients with psoriatic arthritis:a nationwide study from the Chinese Registry of Psoriatic Arthritis (CREPAR IV).
- Published in:
- Clinical Rheumatology, 2024, v. 43, n. 3, p. 1063, doi. 10.1007/s10067-023-06859-3
- By:
- Publication type:
- Article
The Saudi consensus recommendations for the management of psoriatic arthritis (2023).
- Published in:
- Clinical Rheumatology, 2024, v. 43, n. 3, p. 879, doi. 10.1007/s10067-024-06867-x
- By:
- Publication type:
- Article
The risk factors for uveitis among psoriatic arthritis patients: a population-based cohort study.
- Published in:
- Clinical Rheumatology, 2024, v. 43, n. 3, p. 1053, doi. 10.1007/s10067-023-06834-y
- By:
- Publication type:
- Article
Similar levels of disease activity and remission rates in patients with psoriatic arthritis and rheumatoid arthritis—results from the Finnish quality register.
- Published in:
- Clinical Rheumatology, 2024, v. 43, n. 2, p. 633, doi. 10.1007/s10067-023-06850-y
- By:
- Publication type:
- Article
Burden of Disease in Psoriatic Arthritis in Latin America: a Systematic Literature Review.
- Published in:
- Clinical Rheumatology, 2024, v. 43, n. 2, p. 677, doi. 10.1007/s10067-023-06838-8
- By:
- Publication type:
- Article
Radiological progression and predictive factors in psoriatic arthritis: insights from a decade-long retrospective cohort study.
- Published in:
- Clinical Rheumatology, 2024, v. 43, n. 1, p. 259, doi. 10.1007/s10067-023-06839-7
- By:
- Publication type:
- Article
What is the association of depression with clinical response to therapy in patients with psoriatic arthritis treated with biologic disease-modifying antirheumatic drugs?
- Published in:
- Clinical Rheumatology, 2024, v. 43, n. 1, p. 251, doi. 10.1007/s10067-023-06806-2
- By:
- Publication type:
- Article
The childhood arthritis radiographic score of the hip: the proposal cut-off value using cluster analysis.
- Published in:
- Clinical Rheumatology, 2024, v. 43, n. 1, p. 465, doi. 10.1007/s10067-023-06749-8
- By:
- Publication type:
- Article
Earlier clinical response predicts low rates of radiographic progression in biologic-naïve patients with active psoriatic arthritis receiving guselkumab treatment.
- Published in:
- Clinical Rheumatology, 2024, v. 43, n. 1, p. 241, doi. 10.1007/s10067-023-06745-y
- By:
- Publication type:
- Article
The burden of entheseal involvement in systemic lupus erythematosus: a comparative ultrasonograghic study.
- Published in:
- Clinical Rheumatology, 2024, v. 43, n. 1, p. 219, doi. 10.1007/s10067-023-06675-9
- By:
- Publication type:
- Article
Long-term golimumab persistence: Five-year treatment retention data pooled from pivotal Phase III clinical trials in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.
- Published in:
- Clinical Rheumatology, 2023, v. 42, n. 12, p. 3397, doi. 10.1007/s10067-023-06760-z
- By:
- Publication type:
- Article
Is the C-reactive protein-to-albumin ratio the most remarkable simple inflammatory marker showing active disease in patients with axial spondyloarthritis, psoriatic arthritis, and rheumatoid arthritis?
- Published in:
- Clinical Rheumatology, 2023, v. 42, n. 11, p. 2959, doi. 10.1007/s10067-023-06703-8
- By:
- Publication type:
- Article
Autonomic dysfunction and cardiovascular risk in psoriatic arthritis.
- Published in:
- Clinical Rheumatology, 2023, v. 42, n. 10, p. 2635, doi. 10.1007/s10067-022-06484-6
- By:
- Publication type:
- Article
Correction to: Difficult to treat psoriatic arthritis — how should we manage?
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Difficult to treat psoriatic arthritis — how should we manage?
- Published in:
- Clinical Rheumatology, 2023, v. 42, n. 9, p. 2251, doi. 10.1007/s10067-023-06605-9
- By:
- Publication type:
- Article